Literature DB >> 8591822

A new effective method for the evaluation of glycated intact plasma proteins in diabetic subjects.

A Lapolla1, D Fedele, R Seraglia, S Catinella, L Baldo, R Aronica, P Traldi.   

Abstract

The molecular weights of plasma proteins from healthy subjects and from patients with well-or badly-controlled diabetes mellitus have been determined by use of a matrix-assisted laser desorption ionization method, representing a highly accurate technique for the determination of the molecular weight of large biomolecules. Using this approach, different molecular weights of human serum albumin have been found for healthy (66,572-66,694 dalton) and diabetic (66,785-68,959 dalton) subjects. Such differences can be rationalized as being due to the different number of glucose molecules condensed on the protein and/or their further oxidation products; in the case of our diabetic patients this number is in the range of 1.4-14.8. The data show the high validity and specificity of the technique, which allows us to evaluate, without any protein degradation procedure, the number of glucose molecules condensed on a specific protein and ascertain the relationship of this number to the physiopathogenetic conditions of the subjects studied.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591822     DOI: 10.1007/bf00402178

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  15 in total

1.  Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose.

Authors:  A S HUGGETT; D A NIXON
Journal:  Lancet       Date:  1957-08-24       Impact factor: 79.321

2.  Absence of brown product FFI in nondiabetic and diabetic rat collagen.

Authors:  A Lapolla; C Gerhardinger; B Pelli; A Sturaro; E Del Favero; P Traldi; G Crepaldi; D Fedele
Journal:  Diabetes       Date:  1990-01       Impact factor: 9.461

Review 3.  Role of oxidative stress in development of complications in diabetes.

Authors:  J W Baynes
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

Review 4.  Nonenzymatic glycosylation and the pathogenesis of diabetic complications.

Authors:  M Brownlee; H Vlassara; A Cerami
Journal:  Ann Intern Med       Date:  1984-10       Impact factor: 25.391

5.  Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process.

Authors:  D R Sell; V M Monnier
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

6.  Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM.

Authors:  D R Sell; A Lapolla; P Odetti; J Fogarty; V M Monnier
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

7.  Reaction of human serum albumin with aldoses.

Authors:  G M Ghiggeri; G Candiano; G Delfino; C Queirolo; G Vecchio; E Gianazza; P G Righetti
Journal:  Carbohydr Res       Date:  1985-12-15       Impact factor: 2.104

8.  Specific quantitation by HPLC of protein (lysine) bound glucose in human serum albumin and other glycosylated proteins.

Authors:  E Schleicher; O H Wieland
Journal:  J Clin Chem Clin Biochem       Date:  1981-02

9.  Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites.

Authors:  N Iberg; R Flückiger
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  9 in total

1.  Comparison of modification sites formed on human serum albumin at various stages of glycation.

Authors:  Omar S Barnaby; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-10-27       Impact factor: 3.786

2.  Correlation between molecular weight of plasma albumin determined with mass spectrometry and glycation indices in factory workers.

Authors:  Ichiro Nakamoto; Kanehisa Morimoto
Journal:  Environ Health Prev Med       Date:  2004-03       Impact factor: 3.674

3.  Quantitative analysis of glycation sites on human serum albumin using (16)O/(18)O-labeling and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Omar S Barnaby; Chunling Wa; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2010-04-13       Impact factor: 3.786

4.  Quantitative analysis of glycation patterns in human serum albumin using 16O/18O-labeling and MALDI-TOF MS.

Authors:  Omar S Barnaby; Ronald L Cerny; William Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2011-05-13       Impact factor: 3.786

Review 5.  A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.

Authors:  Qibin Zhang; Jennifer M Ames; Richard D Smith; John W Baynes; Thomas O Metz
Journal:  J Proteome Res       Date:  2009-02       Impact factor: 4.466

6.  Matrix-assisted laser desorption/ionization mass spectrometry, enzymatic digestion, and molecular modeling in the study of nonenzymatic glycation of IgG.

Authors:  A Lapolla; D Fedele; M Garbeglio; L Martano; R Tonani; R Seraglia; D Favretto; M A Fedrigo; P Traldi
Journal:  J Am Soc Mass Spectrom       Date:  2000-02       Impact factor: 3.262

Review 7.  Maillard Proteomics: Opening New Pages.

Authors:  Alena Soboleva; Rico Schmidt; Maria Vikhnina; Tatiana Grishina; Andrej Frolov
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

8.  The Burden of Impaired Serum Albumin Antioxidant Properties and Glyco-Oxidation in Coronary Heart Disease Patients with and without Type 2 Diabetes Mellitus.

Authors:  Francesco Piarulli; Cristina Banfi; Maura Brioschi; Alessandra Altomare; Eugenio Ragazzi; Chiara Cosma; Giovanni Sartore; Annunziata Lapolla
Journal:  Antioxidants (Basel)       Date:  2022-07-30

9.  Protein glycation in diabetes as determined by mass spectrometry.

Authors:  Annunziata Lapolla; Laura Molin; Pietro Traldi
Journal:  Int J Endocrinol       Date:  2013-03-13       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.